Arcascope
PrivateLast Round
Grant
Jul 5, 2024
Total Funding Raised
$5.17M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Arcascope operates in Healthcare & Life Sciences and is based in Chantilly, Virginia. Its latest recorded funding round was a Grant round in July 2024.
Arcascope is a healthcare technology company that develops AI-driven digital twins and mathematical models to track and manage circadian rhythms for improved sleep and health.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Clinical Trials, Precision Medicine, Sports & Fitness
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arcascope Comparables
Compare Arcascope with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Timeshifter | 77% | |
| Circadian OS | 70% | |
| Rise Science | 68% |
For institutional investors. Book with your work email.
Arcascope Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 5, 2024 | ||||
| Grant | Sep 1, 2023 | ||||
| Seed | Sep 27, 2022 | ||||
| Grant | Mar 15, 2022 | ||||
| Grant | Jul 15, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Arcascope Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| HealthX Ventures | Seed |
| NIH RADx | Grant |
| Inflect Health | Seed |
| Creative Destruction Lab | Seed |
| AIoT Health | Seed |
| New Dominion Angels | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 59% MoM.
- Jul 26, 2026
Monthly visitors increased 62% MoM.
For institutional investors. Book with your work email.
Arcascope Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Arcascope's valuation, stock price, and market status.
Is Arcascope a public or private company?
Arcascope is a private company.
What is the current stock price of Arcascope?
Arcascope is a private company, so its shares have no public market price. Caplight tracks Arcascope's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Arcascope worth (valuation)?
Valuation information for Arcascope is not publicly available.
Can I buy Arcascope stock?
Arcascope shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Arcascope's last funding round?
Arcascope's most recent funding round was Grant on July 5, 2024.
Who are the main investors in Arcascope?
Key investors in Arcascope include National Cancer Institute, NIH RADx, Supermoon Capital, National Heart, Lung, and Blood Institute.
Will Arcascope IPO soon?
No public IPO plans have been announced for Arcascope.
How can I track Arcascope secondary market activity?
Caplight tracks bids, offers, and trades in Arcascope's shares on secondary markets.